These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11757272)

  • 1. [Autoimmune thrombocytopenias].
    Lefrère F
    Rev Prat; 2001 Sep; 51(14):1558-63. PubMed ID: 11757272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of autoimmune thrombocytopenia in adults].
    Gunsilius E; Seifried E
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():87-98. PubMed ID: 8499757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute idiopathic thrombocytopenic purpura in children. A retrospective evaluation of 120 cases.
    Baronci C; Petrone A; Miano C; Lombardi A; Caniglia M; Russo LA; Luciani M; Pinto RM; Rana I; Caruso R; De Rossi G
    Ann Ist Super Sanita; 1998; 34(4):457-61. PubMed ID: 10234876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of idiopathic thrombocytopenic purpura: new approach to refractory patients.
    Bussel JB
    Semin Oncol; 2000 Dec; 27(6 Suppl 12):91-8. PubMed ID: 11226007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune thrombocytopenic purpura.
    Cines DB; Blanchette VS
    N Engl J Med; 2002 Mar; 346(13):995-1008. PubMed ID: 11919310
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy.
    Duru F; Fisgin T; Yarali N; Kara A
    Pediatr Hematol Oncol; 2002 Jun; 19(4):219-25. PubMed ID: 12051587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: only splenectomy induces a complete remission.
    Louwes H; Vellenga E; Houwerzijl EJ; de Wolf JT
    Ann Hematol; 2001 Dec; 80(12):728-32. PubMed ID: 11797113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
    Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T
    Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Idiopathic thrombocytopenic purpura: diagnostic-therapeutic approach in adults, children and pregnant women].
    Mele A; Offidani M; Corvatta L; Leoni P
    Recenti Prog Med; 1999 Sep; 90(9):482-7. PubMed ID: 10544671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute immune thrombocytopenic purpura. To treat or not to treat?
    Bolton-Maggs P
    Hamostaseologie; 2009 Jan; 29(1):74-5. PubMed ID: 19151852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reassessment of treatment modalities for paediatric patients with chronic immune thrombocytopenia.
    Laws HJ; Janssen G; Borkhardt A
    Hamostaseologie; 2009 May; 29(2):171-6. PubMed ID: 19404521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood acute immune thrombocytopenic purpura: 20 years later.
    Blanchette VS; Carcao M
    Semin Thromb Hemost; 2003 Dec; 29(6):605-17. PubMed ID: 14719177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-institution, 20-year prospective experience with an affordable Fc-receptor blockade method to treat patients with chronic, refractory autoimmune thrombocytopenic purpura.
    Estrada-Gómez R; Vargas-Castro O; Oropeza-Borges M; González-Carrillo ML; Pérez-Romano B; Ruiz-Argüelles GJ
    Rev Invest Clin; 2007; 59(6):424-7. PubMed ID: 18402333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current therapies in primary immune thrombocytopenia.
    Pels SG
    Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of IVIG action in immune thrombocytopenic purpura.
    Hansen RJ; Balthasar JP
    Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN; Kozuch P; Varma M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases.
    Arnal C; Piette JC; Léone J; Taillan B; Hachulla E; Roudot-Thoraval F; Papo T; Schaeffer A; Bierling P; Godeau B
    J Rheumatol; 2002 Jan; 29(1):75-83. PubMed ID: 11824975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.